Arovella Therapeutics Limited (ASX:ALA)
Australia
· Delayed Price · Currency is AUD 0.0730
-0.0040 (-5.19%)
Mar 9, 2026, 4:10 PM AEST
Arovella Therapeutics Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Net Income | -7.93 | -7.51 | -8.75 | -10.18 | -8.62 | -5.05 | Upgrade
|
| Depreciation & Amortization | 0.12 | 0.11 | 0.04 | 0.14 | 0.2 | 0.2 | Upgrade
|
| Other Amortization | - | - | - | 0.69 | 0.36 | 0.45 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 1.56 | 0.85 | 1.25 | Upgrade
|
| Stock-Based Compensation | 0.84 | 0.84 | 1.05 | 0.87 | 0.58 | 0.04 | Upgrade
|
| Other Operating Activities | 0.52 | 0.01 | 0.1 | 0.01 | 0.44 | 0.02 | Upgrade
|
| Change in Accounts Receivable | - | - | -0.01 | 0.03 | 0.5 | 0.34 | Upgrade
|
| Change in Accounts Payable | -0.6 | -0.6 | 0.58 | 0.22 | -0.27 | -0.45 | Upgrade
|
| Change in Other Net Operating Assets | 0.22 | 0.22 | 0.07 | 0.26 | -0.3 | -0.34 | Upgrade
|
| Operating Cash Flow | -6.82 | -6.93 | -6.91 | -6.4 | -6.27 | -3.54 | Upgrade
|
| Capital Expenditures | -0.1 | -0.41 | -0.13 | -0 | -0.04 | -0.17 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0.1 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | -0.53 | -0.35 | Upgrade
|
| Other Investing Activities | -0.02 | -0.02 | -0.05 | - | - | - | Upgrade
|
| Investing Cash Flow | -0.12 | -0.43 | -0.18 | 0.1 | -0.57 | -0.51 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -0.07 | -0.07 | -0.06 | Upgrade
|
| Total Debt Repaid | - | - | - | -0.07 | -0.07 | -0.06 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -0.07 | -0.07 | -0.06 | Upgrade
|
| Issuance of Common Stock | 15.89 | 16.81 | 14.61 | 5.48 | 6.26 | 10.58 | Upgrade
|
| Other Financing Activities | -1.3 | -1.29 | - | - | - | -0.72 | Upgrade
|
| Financing Cash Flow | 14.59 | 15.52 | 14.61 | 5.41 | 6.19 | 9.8 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.03 | 0 | 0.02 | - | - | - | Upgrade
|
| Net Cash Flow | 7.62 | 8.16 | 7.54 | -0.9 | -0.65 | 5.74 | Upgrade
|
| Free Cash Flow | -6.93 | -7.34 | -7.04 | -6.4 | -6.3 | -3.71 | Upgrade
|
| Free Cash Flow Margin | -215.75% | -213.45% | -360.80% | -439.99% | -2130.85% | -374.92% | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Cash Interest Paid | - | - | - | 0.02 | 0.18 | 0.03 | Upgrade
|
| Cash Income Tax Paid | - | -3.3 | -1.94 | -1.05 | -0.52 | -1.12 | Upgrade
|
| Levered Free Cash Flow | -4.4 | -4.8 | -4.42 | -3.19 | -4.37 | -2.2 | Upgrade
|
| Unlevered Free Cash Flow | -4.4 | -4.8 | -4.42 | -3.18 | -4.25 | -2.19 | Upgrade
|
| Change in Working Capital | -0.38 | -0.38 | 0.64 | 0.51 | -0.07 | -0.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.